Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A TEICHER

Showing results (151-160 of 372) with videos related to

Pageof 38
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1996
Comparison of several antiangiogenic regimens alone and with cytotoxic therapies in the Lewis lung carcinomaB A Teicher, S A Holden, G Ara, et al.
In Vivo (Athens, Greece)|March 24, 1998
Transforming growth factor-beta 1 overexpression produces drug resistance in vivo: reversal by decorinB A Teicher, M Ikebe, G Ara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Acute in vivo resistance in high-dose therapyB A Teicher, G Ara, S R Keyes, et al.
International Journal of Cancer|January 2, 1993
Interaction of topoisomerase I inhibitors with radiation in cis-diamminedichloroplatinum(II)-sensitive and -resistant cells in vitro and in the FSAIIC fibrosarcoma in vivoR E Boscia, T Korbut, S A Holden, et al.
Journal of Medicinal Chemistry|January 31, 1997
Analogues of N alpha-(4-amino-4-deoxypteroyl)-N delta-hemiphthaloyl-L-ornithine (PT523) modified in the side chain: synthesis and biological evaluationA Rosowsky, C M Vaidya, H Bader, et al.
In Vivo (Athens, Greece)|August 17, 2000
Cryptophycin 52 and cryptophycin 55 in sequential and simultaneous combination treatment regimens in human tumor xenograftsB A Teicher, P Forler, K Menon, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Reduced oxygenation in a rat mammary carcinoma after chemo- or radiation therapy and reoxygenation with perflubron emulsion/carbogen breathingB A Teicher, E A Sotomayor, N P Dupuis, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Protection of bone-marrow granulocyte-macrophage colony-forming units in mice bearing in vivo alkylating-agent-resistant EMT-6 tumorsB A Teicher, D Chatterjee, J T Liu, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Cyclooxygenase and lipoxygenase inhibitors as modulators of cancer therapiesB A Teicher, T T Korbut, K Menon, et al.
The Cancer Journal From Scientific American|May 1, 1995
Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathingB A Teicher, S A Holden, G Ara, et al.
Pageof 38

Showing results (151-160 of 372) with videos related to

Sort By:
Pageof 38
Cancer Chemotherapy and Pharmacology|January 1, 1996
Comparison of several antiangiogenic regimens alone and with cytotoxic therapies in the Lewis lung carcinomaB A Teicher, S A Holden, G Ara, et al.
In Vivo (Athens, Greece)|March 24, 1998
Transforming growth factor-beta 1 overexpression produces drug resistance in vivo: reversal by decorinB A Teicher, M Ikebe, G Ara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Acute in vivo resistance in high-dose therapyB A Teicher, G Ara, S R Keyes, et al.
International Journal of Cancer|January 2, 1993
Interaction of topoisomerase I inhibitors with radiation in cis-diamminedichloroplatinum(II)-sensitive and -resistant cells in vitro and in the FSAIIC fibrosarcoma in vivoR E Boscia, T Korbut, S A Holden, et al.
Journal of Medicinal Chemistry|January 31, 1997
Analogues of N alpha-(4-amino-4-deoxypteroyl)-N delta-hemiphthaloyl-L-ornithine (PT523) modified in the side chain: synthesis and biological evaluationA Rosowsky, C M Vaidya, H Bader, et al.
In Vivo (Athens, Greece)|August 17, 2000
Cryptophycin 52 and cryptophycin 55 in sequential and simultaneous combination treatment regimens in human tumor xenograftsB A Teicher, P Forler, K Menon, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Reduced oxygenation in a rat mammary carcinoma after chemo- or radiation therapy and reoxygenation with perflubron emulsion/carbogen breathingB A Teicher, E A Sotomayor, N P Dupuis, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Protection of bone-marrow granulocyte-macrophage colony-forming units in mice bearing in vivo alkylating-agent-resistant EMT-6 tumorsB A Teicher, D Chatterjee, J T Liu, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Cyclooxygenase and lipoxygenase inhibitors as modulators of cancer therapiesB A Teicher, T T Korbut, K Menon, et al.
The Cancer Journal From Scientific American|May 1, 1995
Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathingB A Teicher, S A Holden, G Ara, et al.
Pageof 38